22 Stocks Moving in Thursday's Pre-Market Session
Author: Lisa Levin | July 15, 2021 07:32am
Gainers
- Huadi International Group Co., Ltd. (NASDAQ:HUDI) shares rose 63.2% to $8.03 in pre-market trading after jumping around 8% on Wednesday.
- Verb Technology Company, Inc. (NASDAQ:VERB) shares rose 22.9% to $3.06 in pre-market trading. Verb Technology shares gained 12% on Wednesday after the company, and SHOP.COM, announced they partnered to launch SHOP LIVE, a customized, interactive and live-streaming channel.
- Cinedigm Corp. (NASDAQ:CIDM) shares rose 21.3% to $1.31 in pre-market trading after the company reported preliminary fourth-quarter FY21 revenue growth of 197% year-on-year to $8.3 million, above the analyst consensus of $7.7 million.
- Alterity Therapeutics Limited (NASDAQ:ATHE) shares rose 19.4% to $1.66 in pre-market trading.
- Arlo Technologies, Inc. (NYSE:ARLO) rose 18.4% to $7.07 in pre-market trading. Arlo Technologies is expected to report Q2 earnings on August 4.
- Datasea Inc. (NASDAQ:DTSS) rose 11.1% to $4.42 in pre-market trading. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd recently inked six purchase and distribution agreements to provide 5G Message-marketing Cloud Platform (5G MMCP) Version 3.0 and further enhanced product availability nationwide in China by adding new district partners.
- Lipocine Inc. (NASDAQ:LPCN) shares rose 7.8% to $1.39 in pre-market trading after the company entered into a settlement and license agreement with Clarus Therapeutics to resolve claims in the ongoing intellectual property litigation and interference proceeding.
- SciPlay Corporation (NASDAQ:SCPL) rose 7.2% to $16.47 in pre-market trading. Scientific Games submitted a proposal to acquire public shares of SciPlay.
- Allied Healthcare Products, Inc. (NASDAQ:AHPI) shares rose 6.9% to $6.67 in pre-market trading after dipping 31% on Wednesday.
- SGOCO Group, Ltd. (NASDAQ:SGOC) rose 6.5% to $14.06 in pre-market trading after jumping around 38% on Wednesday. The company recently regained Nasdaq compliance.
- American International Group, Inc. (NYSE:AIG) rose 5.2% to $48.83 in pre-market trading after the company reported strategic partnership with Blackstone for its life & retirement business and sale to Blackstone of certain affordable housing assets.
- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) shares rose 5.2% to $1.82 in pre-market trading following a 5% drop on Wednesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Immunic, Inc. (NASDAQ:IMUX) fell 13.9% to $10.25 in pre-market trading after the company reported a proposed public offering of common stock.
- Galapagos NV (NASDAQ:GLPG) fell 11.3% to $58.35 in pre-market trading after the company reported topline results with tyrosine kinase 2 (TYK2) inhibitor GLPG3667 in a Phase 1b study in psoriasis patients.
- Dogness (International) Corporation (NASDAQ:DOGZ) shares fell 7.7% to $2.17 in pre-market trading. Dogness recently said its products will be available on Home Depot’s HomeDepot.com, including the Dogness 3.2L Smart Fountain Plus and its smart retractable leashes..
- Yunhong CTI Ltd. (NASDAQ:CTIB) fell 7.3% to $2.68 in pre-market trading after jumping over 10% on Wednesday.
- Marine Petroleum Trust (NASDAQ:MARPS) fell 7.2% to $4.50 in pre-market trading.
- Pop Culture Group Co., Ltd (NASDAQ:CPOP) shares fell 7.7% to $9.09 in pre-market trading after dropping 12% on Wednesday.
- Bon Natural Life Limited (NASDAQ:BON) shares fell 6.6% to $11.10 in pre-market trading after jumping around
- 34% on Wednesday.
- MorphoSys AG (NASDAQ:MOR) fell 6.6% to $16.92 in pre-market trading. MorphoSys reported the successful completion of its earlier announced cash tender offer for all outstanding shares of Constellation Pharmaceuticals.
- U.S. Energy Corp. (NASDAQ:USEG) fell 6.4% to $4.72 in pre-market trading after surging over 20% on Wednesday.
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares fell 5.5% to $0.7652 in pre-market trading. The FDA recently accepted InVivo Therapeutics preclinical module, which is one of three individual modules required for the Company's humanitarian device exemption (HDE) application for its Neuro-Spinal Scaffold implant.
Posted In: AHPI AIG ARLO ATHE BON CATB CIDM CPOP CTIB DOGZ DTSS GLPG HUDI IMUX LPCN MARPS MOR NVIV SCPL SGOC